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Pore formationFluorescence correlation spectroscopy (FCS) is a powerful experimental technique that in recent years has found
numerous applications for studying biological phenomena. In this article, we scrutinize one of these applications,
namely, FCS as a technique for studying leakage of ﬂuorescent molecules from large unilamellar lipid vesicles.
Speciﬁcally, we derive the mathematical framework required for using FCS to quantify leakage of ﬂuorescent
molecules from large unilamellar lipid vesicles, and we describe the appropriate methodology for successful
completion of FCS experiments. By use of this methodology, we show that FCS can be used to accurately quantify
leakage of ﬂuorescent molecules from large unilamellar lipid vesicles, including leakage of ﬂuorescent molecules
of different sizes. To demonstrate the applicability of FCS, we have investigated the antimicrobial peptide
mastoparan X. We show that mastoparan X forms transient transmembrane pores in POPC/POPG (3:1) vesicles,
resulting in size-dependent leakage of molecules from the vesicles.We conclude the paper by discussing some of
the advantages and limitations of FCS as compared to other existing methods to measure leakage from large
unilamellar lipid vesicles.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Many membrane-active agents, such as antimicrobial peptides, can
compromise the permeability barrier constituted by phospholipid
membranes [1,2]. In order to study themembrane-destabilizing proper-
ties of these agents, synthetic large unilamellar lipid vesicles (LUVs) are
often employed as model membrane systems. In typical experiments,
LUVs are incubated together with a membrane-destabilizing agent
that induces leakage of self-quenched ﬂuorescent molecules from the
LUVs. Leakage is then detected as an increase in ﬂuorescence emission
intensity due to ﬂuorescence dequenching upon release of the ﬂuores-
cent molecules from the LUVs [3,4]. Other approaches than the
dequenching-based detection approaches have also been employed to
detect leakage of ﬂuorescent molecules from LUVs, for example, based
on chromatographic separation of LUVs from released ﬂuorescent mole-
cules [5,6].
Another spectroscopic technique that has been used to study leakage
of ﬂuorescent molecules from LUVs is ﬂuorescence correlation spectros-
copy (FCS) [7–10]. In FCS, ﬂuctuations in emission intensity fromanotechnology, DTU Nanotech,
ilding 423, DK-2800 Kongens
n), jhen@kemi.dtu.dkﬂuorescent particles diffusing across a small excitation volume are
statistically analyzed via an autocorrelation function. The shape of this
autocorrelation function depends, i.a., on the concentration and diffu-
sion properties of the ﬂuorescent particles [11,12]. Since ﬂuorescent
molecules encapsulated in LUVs are restricted to diffuse together with
the LUVs, they will effectively have the same diffusion coefﬁcient as
the LUVs; see Fig. 1A. In contrast, free ﬂuorescent molecules will have
a higher diffusion coefﬁcient than the LUVs; see Fig. 1B. Thereby,ﬂuores-
cent molecules encapsulated in LUVs will make a different contribution
to the autocorrelation function than the free ﬂuorescent molecules,
allowing us to use FCS to study the leakage process. In addition, by eval-
uating the diffusion properties of a ﬂuorophore anchored to the mem-
brane of the LUVs, FCS can also be used to evaluate the state of the
LUVs during leakage; see Fig. 1C [13]. If leakage is due to formation of
transmembrane pores, the LUVs will remain intact, and the diffusion
coefﬁcient of the lipid-anchored ﬂuorophore will not change during
the leakage process; see Fig. 1D. If leakage is due to membrane solubili-
zation/micellization, the diffusion coefﬁcient of the lipid-anchored
ﬂuorophore will increase as the ﬂuorophore is incorporated into
micelles. If vesicle aggregation and/or fusion occurs during leakage, the
diffusion coefﬁcient of the lipid-anchored ﬂuorophore will decrease.
In this article,we evaluate the requirements for using FCS to quantify
leakage of ﬂuorescentmolecules from LUVs. In particular, we derive the
necessary mathematical framework and we present an appropriate
experimental protocol that allows for FCS to beused to quantify leakage.
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Fig. 1. Illustration of how the diffusion properties of ﬂuorescent molecules are affected by
leakage. (A) When ﬂuorescent molecules are encapsulated in LUVs, they will be restricted
to diffuse together with the LUVs. (B) Released ﬂuorescent molecules will have a different
diffusion coefﬁcient than encapsulated ﬂuorescent molecules. (C) When ﬂuorophores
are anchored to the membranes of the LUVs, they will diffuse together with the LUVs.
(D) If leakage is due to formation of transmembrane pores, the diffusion coefﬁcient of the
lipid-anchored ﬂuorophore will not change.
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FCS is to be used to accurately quantify leakage.
To demonstrate the potential of FCS as a method to study leakage,
we consider the natural antimicrobial peptide mastoparan X (MPX),
isolated from the venom of the hornet Vespa xanthoptera [14]. MPX
displays many archetypal features of antimicrobial peptides [15–18],
including a short sequence of 14 amino acid residues, a strongnet charge
of +4, and an amphipathic α-helical membrane-bound structure [19,
20]. It has previously been shown that MPX induces partial transient
leakage of ﬂuorescent molecules from LUVs, and that this leakage
process is dependent on the size of the encapsulated molecules
[21–25]. Here, we conﬁrm these observations as we show that MPX-
induced leakage from POPC/POPG (3:1) LUVs is due to the formation
of transient transmembrane pores and that the size of these pores
leads to size-selective leakage of ﬂuorescent molecules ranging in size
from ~500 Da to ~10 kDa.
We conclude the article by discussing some of the advantages and
limitations of FCS as a method for studying leakage from LUVs.
2. Theory
We ﬁrst consider the fundamental equations of FCS. For a single
species of ﬂuorescent molecules diffusing freely into and out of a
three-dimensional Gaussian excitation volume, the autocorrelation
function, G(τ), without triplet state contribution is given by [10,11]
G τð Þ ¼ 1
N
g τð Þ ¼ 1
N
1þ τ
τD
 −1
1þ τ
S2τD
 −12 ð1Þ
where τ is the lag time, N is the average number of ﬂuorescent mole-
cules in the excitation volume, S is the ratio of the axial to radial dimen-
sions of the excitation volume, and τD is the characteristic translational
diffusion time of the ﬂuorescent molecules. In case there are multiple
diffusing species of ﬂuorescent molecules, the autocorrelation function
is a weighted sum of the autocorrelation functions of the individual
species [10,11]:
G τð Þ ¼ 1
F2t
Xn
i¼1
B2i Nigi τð Þ ¼
Xn
i¼1
Aigi τð Þ ð2Þwhere Bi is the brightness (photon count rate per ﬂuorescentmolecule)
of the ﬂuorescentmolecules of the ith species, Ni is the mean number of
ﬂuorescentmolecules of the ith species in the excitation volume, gi(τ) is
the diffusion autocorrelation function (deﬁned in Eq. (1)) of theﬂuores-
centmolecules ith species,Ai is the amplitude of the term in the autocor-
relation function corresponding to the diffusion of the ﬂuorescent
molecules of the ith species, and
Ft ¼
Xn
i¼1
BiNi ð3Þ
is the total photon count rate.
Next, we consider a solution of LUVs to which a leakage-inducing
agent has been added. In this solution, there are two distinct diffusing
species: free ﬂuorescent molecules (index f) and LUVs encapsulating
ﬂuorescent molecules (index v). According to Eq. (2), the autocorrela-
tion function is then given by
G τð Þ ¼ A fg f τð Þ þ Avgv τð Þ ð4Þ
where
A f ¼
B2fN f
F2t
ð5Þ
and
Av ¼
B2vNv
F2t
: ð6Þ
The fraction, L, of ﬂuorescent molecules that has leaked out of the
LUVs upon addition of the leakage-inducing agent is given by
L ¼ N f
N f100
ð7Þ
where Nf100 is the value of Nf evaluated for an equivalent solution of
LUVs in which all LUVs have released all of their contents. By the use
of Eq. (5), we can rewrite Eq. (7) to
L ¼ A f F
2
t
A f100 F
2
t100
: ð8Þ
To further rewrite Eq. (8), we use that the total photon count rate of
a solution of LUVs to which a leakage-inducing agent has been added
can be split into two terms: a term stemming from ﬂuorescent
molecules that have leaked out of the LUVs after addition of leakage-
inducing agent to the solution and a term stemming from ﬂuorescent
molecules that have remained encapsulated in the LUVs after addition
of leakage-inducing agent to the solution. Since both of these terms
are a function of leakage, L, we get the following expression for the
total photon count rate, Ft:
Ft ¼ B fN f100Lþ BeN f100 1−Lð Þ: ð9Þ
where Be is the brightness of encapsulated ﬂuorescentmolecules. (Note
that Be differs from Bv in that Be is the photon count rate per encapsulat-
ed ﬂuorescent molecule whereas Bv is the apparent photon count rate
per LUV.) By inserting Eq. (9) into Eq. (8) and using that L= 100% for
an LUV solution in which all LUVs have released all of their contents, a
quadratic equation in L is obtained
A f 1−kð Þ2L2 þ 2A fk 1−kð Þ−A f100ð ÞLþ A fk2 ¼ 0 ð10Þ
where k= Be/Bf is the brightness ratio between encapsulated and free
ﬂuorescent molecules.
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Eq. (10) to calculate leakage, L, are given in Section 3.3.2. However,
before proceeding to this section, a few comments should be made
regarding Eq. (10). Firstly, it should be noted that when setting k = 1
in Eq. (10), we obtain an expression that is completely analogous to
previously derived expressions to determine the LUV-bound fractions
of ﬂuorescently-labeled proteins by FCS [26,27]. However, in the
present study, this simpliﬁed expression will not be used as k≠ 1 in
our experimental system.
Secondly, it should be noted that as Ft in our experimental setup is a
direct output parameter of each individual FCS recording, Nf and Nf100
could both be estimated directly from experimental autocorrelation
curves by the use of Eqs. (4) and (5), provided that Bf is determined in
a control experiment. Then leakage could be calculated directly using
Eq. (7). This approach would certainly be simpler than solving the
quadratic equation in Eq. (10). However, in our experience, this
approach leads to larger uncertainties in the determined values of L
thanwhen solving Eq. (10). The reason for this is related to small exper-
imental variations in Ft between individual experiments; since Ft is
squared in Eq. (5), these small variations in Ft will lead to relatively
larger variations in the determined values of L. In contrast, since the
brightness ratio parameter, k, can be determined by averaging multiple
experiments, Eq. (10) provides a more robust and accurate approach to
calculate leakage; in other words, Eq. (10) is based on more precise
estimates of the relative changes of Ft as a function of L than what is
attainable by actually recording Ft in each individual experiment.
Finally, it should be mentioned that Eq. (10) is also applicable for
calculating leakage of ﬂuorescent molecules with a brightness distribu-
tion, such as ﬂuorescently-labeled dextrans. This point is discussed in
further detail in Section S1 in the Supporting material.
3. Materials and methods
3.1. Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-
palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)], sodi-
um salt (POPG), and 1-palmitoyl-2-[11-(dipyrrometheneboron
diﬂuoride)undecanoyl]-sn-glycero-3-phosphocholine (TopFluor
PC) were purchased from Avanti Polar Lipids (Alabaster, AL). N-(2-
Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES) and the
corresponding sodium salt (HEPES-Na), and NaCl were purchased
from Sigma-Aldrich (St. Louis, MO). Rhodamine 6G chloride (Rh6G),
Alexa Fluor 488 hydrazide, sodium salt (Alexa488), Alexa Fluor 488
dextran, 3000 MW (Alexa488-3kMW), and Alexa Fluor 488 dextran,
10,000 MW (Alexa488-10kMW) were purchased from Life Technolo-
gies (Carlsbad, CA). Mastoparan X (MPX) was purchased from GL
Biochem (Shanghai, China) and further puriﬁed by semi-preparative
HPLC (Waters semi-preparative HPLC equipped with a Waters 600
pump & controller and aWaters 2489 UV/vis detector, Waters, Milford,
MA). The purity of the puriﬁed peptide was assessed to be N99% by
analytical HPLC (Gilson analytical HPLC equipped with a Gilson 321
HPLC pump and a Gilson 155 UV/vis detector, Gilson, Middleton, MI).
Furthermore, the peptide identity was conﬁrmed by MALDI-TOF
(Bruker Reﬂex IV MALDI-TOF spectrometer, Bruker, Billerica, MA).
3.2. Sample preparation
3.2.1. LUV preparation and characterization
POPC/POPG (3:1) solutions were prepared in chloroform/methanol
(9:1). The organic solvent was removed under a gentle stream of nitro-
gen. The samples were subsequently kept in vacuum overnight to
remove the residual solvent. The lipid ﬁlms were hydrated in HEPES
buffer (10 mM HEPES, 100 mM NaCl, pH 7.4) with vigorous vortexing
every 5 min for a period of 30 min. The hydrated lipid suspensions
were then subject to 5 freeze–thaw cycles by alternately placing thesample vials in an isopropanol/dry ice bath and a warm water bath.
Next, the lipid suspensions were extruded 21 times through a 100 nm
polycarbonate ﬁlter (Whatman, Maidstone, UK) using a mini-extruder
(Avanti Polar Lipids) to form large unilamellar vesicles (LUVs). The
size of the LUVs was checked by dynamic light scattering (ZetaPALS,
Brookhaven Instruments, Holtsville, NY). Phosphorus concentrations
of the LUV solutions were determined using the method of Rouser
et al. [28], albeit with slightly modiﬁed reagent concentrations.
To prepare LUVs labeled with TopFluor PC, POPC/POPG (3:1) with
0.1 mol% TopFluor PC was dissolved in the initial chloroform/methanol
(9:1) solution. The rest of the preparation protocol was then completely
identical to the protocol used for preparation of unlabeled LUVs.
To prepare LUVs encapsulating ﬂuorescent molecules, the HEPES
buffer used to hydrate the POPC/POPG (3:1) lipid ﬁlms was prepared
with 4 or 30 μM Alexa488, 5 μM Alexa488-3kMW, or 2.5 μM Alexa488-
10kMW. Concentrations of these ﬂuorescent molecules were deter-
mined from absorbance values recorded by a NanoDrop 2000c spectro-
photometer (NanoDrop Products,Wilmington, DE), utilizing (i) that the
extinction coefﬁcient of Alexa488 at maximum absorbance (usually at
495 nm) is 71,000 cm −1M−1 and (ii) that the degree of labeling of
Alexa488-3kMW and Alexa488-10kMW was 1 and 2, respectively, as
stated by the manufacturer. The rest of the preparation protocol was
completely identical to the protocol for unlabeled LUVs, except that
before the determination of phosphorous concentrations, LUV solutions
were run on a size exclusion chromatography column (Sepharose CL-4B,
GE Healthcare, Uppsala, Sweden) to remove the free ﬂuorescent mole-
cules from the LUV solutions.
3.2.2. MPX stock solutions
MPX stock solutions were prepared in HEPES buffer. To prevent loss
ofMPXdue to adsorption to vial surfaces,MPX stock solutionswere gen-
erally handled in Protein LoBind tubes (Eppendorf, Hamburg, Germany)
andat high concentrations of at least 100 μM. To calculate the concentra-
tion of MPX stock solutions, the extinction coefﬁcient of MPX at 220 nm
was calculated to be 40,100 cm −1M−1 by correlating the MPX concen-
tration determined by an Antek 8060 chemiluminescent nitrogen detec-
tor (PAC, Houston, TX) to the absorbance of the same MPX sample,
determined by aNanoDrop 2000c spectrophotometer. Given this extinc-
tion coefﬁcient,MPX concentrations of stock solutionswere then always
determined by recording the absorbance at 220 nmusing theNanoDrop
2000c spectrophotometer.
3.3. FCS experiments
3.3.1. Experimental setup
FCS measurements were performed using a DCS-120 confocal scan-
ning FLIM system(Becker &Hickl, Berlin, Germany) connected to a Zeiss
Axio Observer Z1 inverted microscope equipped with a C-Apochromat
40x/1.2 W Corr UV–VIS-IR water immersion objective (Carl Zeiss, Jena,
Germany). The excitation source for the system was a 473 nm picosec-
ond diode laser (BDL-473-SMC, Becker & Hickl) operated at a pulse
repetition rate of 50 MHz. The incident excitation power at the objective
rear aperturewasmeasured by a PM100Doptical powermeter (Thorlabs,
Goteborg, Sweden). After passing through a 485 nm long-pass ﬁlter
(HQ485LP, Becker &Hickl) and a confocal pinhole, theﬂuorescence emis-
sion was detected with a HPM-100-40 hybrid detector connected to a
SPC-150 module (Becker & Hickl). Lifetime-gating was used to partially
suppress background noise. SPCM software (Becker & Hickl) was used
to calculate the experimental autocorrelation curves. The curves were
subsequently exported to be ﬁtted by MATLAB (The MathWorks, Natick,
MA). All samples were measured in uncoated μ-slide 8 wells (ibidi,
Martinsried, Germany) by positioning the laser focus ~50 μm above the
top of the coverslip. The acquisition time for all experiments was 5 min.
The effective excitation volumewas determined to be 1.0 fL by calibration
with Alexa488 [29]. From the same calibration experiments, the S-
parameter was determined to be 8.6 by weighted least squares ﬁtting
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autocorrelation function (Eq. (1)) [30]. The S-parameter was always
ﬁxed to this value when ﬁtting all other experimental autocorrelation
curves. Except for the experiments determining the S-parameter, all
autocorrelation curves in this article were analyzed using unweighted
least squares ﬁtting. Autocorrelation curves dominated by single bright
events were discarded in the data analysis.
3.3.2. Protocol to treat the FCS data
To conduct a leakage experiment, a number of sampleswith constant
concentrations of ﬂuorescent molecule-containing LUVs but varying
concentrations of leakage-inducing agent should be mixed to prepare
a number of samples with leakage levels ranging between 0% and
100%. Next, FCS should be used to acquire experimental autocorrelation
curves from each of these samples. Leakage of the ﬂuorescentmolecules
can then be quantiﬁed by treating the autocorrelation curves with the
following protocol.
1. Determine the LUVdiffusion time, τDv, byﬁtting the single-component
autocorrelation function (Eq. (1)) to the autocorrelation curve record-
ed from the LUV solutionwith 0% leakage, i.e., from an LUV solution to
which no leakage-inducing agent has been added.
2. Determine the diffusion time of free ﬂuorescent molecules, τDf, by
ﬁtting the single-component autocorrelation function (Eq. (1)) to
the autocorrelation curve recorded from the LUV solution with
100% leakage, i.e., from an LUV solution to which so much leakage-
inducing agent has been added that all of the LUVs have released all
of their contents. Complete leakage should be conﬁrmed by compar-
ing the determined value of τDf to diffusion times determined from
solutions preparedwith only free ﬂuorescentmolecules andno LUVs.
3. Determine the correction parameter z0 (see below for discussion
about the parameter) by ﬁtting the autocorrelation curve acquired
from the solution with 0% leakage used in Step 1 with the equation
G τð Þ ¼ Av0 z0g f τð Þ þ gv τð Þð Þ ð11Þ
with τDv and τDf keptﬁxed to the values determined in Steps 1 and 2,
respectively. Av0 is a ﬂoating parameter of the ﬁt but it is not used in
the subsequent data analysis.
4. Determine Af for each autocorrelation curve of the leakage experi-
ment by ﬁtting each curvewith amodiﬁed two-component autocor-
relation function:
G τð Þ ¼ A f þ z0Avð Þg f τð Þ þ Avgv τð Þ ð12Þ
with τDv and τDf kept ﬁxed to the values determined in Steps 1 and 2,
respectively, and z0 keptﬁxed to the value determined in Step 3. Av is a
ﬂoating parameter of the ﬁt but it is not used in the subsequent data
analysis. The value of Af100 is determined from the autocorrelation
curve acquired from the LUV solutionwith100% leakageused in Step2.
5. Determine the brightness ratio, k, using the equation
k ¼ F0
F100
ð13Þ
where F0 and F100 are the photon count rates of the solutionswith 0%
and 100% leakage used in Steps 1 and 2, respectively. In general, k
should be determined by averaging multiple experiments.
6. Solve Eq. (10) for L using each of the values of Af determined in Step
4 togetherwith the value of Af100 determined in Step 4 and the value
of k determined in Step 5.The experimental autocorrelation curves recorded from LUV solu-
tions with 0% leakage were ﬁtted well with a one-component autocor-
relation function (Eq. (1)). When these curves were ﬁtted with a two-
component autocorrelation function (Eq. (4)) we did not observe a
signiﬁcant improvement in the quality of the ﬁt; yet, a small but non-
zero value of Af was obtained from the ﬁt in these situations due to
whatmust be described as a typical dataﬁtting artifact that ubiquitously
occurs whenever a superﬂuous parameter is added to the data ﬁtting
model. The correction parameter z0 was introduced in Steps 3 and 4 to
correct for this small but non-zero value of Af at 0% leakage. If z0 was
not included in the protocol, then Af≠ 0 for solutions with 0% leakage
and L would be slightly overestimated, especially at low values of L.
Along these lines, we have also found that similar data ﬁtting arti-
facts might give rise to a small but non-zero value of Av when ﬁtting
Eq. (4) to solutions with only free dye. This effect might slightly bias
the values of Af obtained at 100% leakage. However, because we have
deﬁned that Af100 is the value of Af at 100% leakage, this effect will not
lead to biases in the calculated values of L; therefore, we did not correct
for this effect in the data ﬁtting.
In our experimental setup, the typical value of τDv was ~4700 μs,
albeit variations between individual LUVbatcheswere observed. The typ-
ical values of τDf were ~43 μs for Alexa488, ~100 μs for Alexa488-3kMW,
and ~210 μs for Alexa488-10kMW. The typical values of z0were 0.033 for
Alexa488, 0.028 for Alexa488-3kMW, and 0.025 for Alexa488-10kMW.
Typical leakage experiments were conducted using an excitation power
of 10.9 μW, corresponding to k = 0.85 for Alexa488, k = 0.96 for
Alexa488-3kMW, and k= 0.95 for Alexa488-10kMW.
3.3.3. Accuracy of the FCS method
Series of samples with varying degrees of encapsulated/free ﬂuores-
cent molecules and constant total concentration of ﬂuorescent mole-
cules were prepared in order to simulate a leakage experiment. Brieﬂy,
the samples were prepared by mixing varying volumes of (i) a stock
solution with 1 mM POPC/POPG (3:1) LUV encapsulating 4 μM
Alexa488, 5 μM Alexa488-3kMW, or 2.5 μM Alexa488-10kMW with
(ii) a stock solution with free Alexa488, Alexa488-3kMW, or Alexa488-
10kMW, respectively, with total molecular concentrations identical to
those of the LUV stock solutions. The mixed samples were vigorously
vortexed before being transferred to the μ-slide 8 wells for examination
by FCS. Experiments were conducted with an excitation power of
10.9 μW. The experimentally acquired autocorrelation curveswere treat-
ed by the data treatment protocol introduced in the previous section.
3.3.4. Experimental pitfalls
We considered three effects that might compromise the accuracy of
leakage values determined by FCS. Firstly, we evaluated the effect of the
number of ﬂuorescent molecules encapsulated per LUV, eB . For this
purpose, we prepared two series of samples to simulate leakage exper-
iments for two different values of eB . These series of samples were
prepared from stock solutions of (i) 1mMPOPC/POPG (3:1) LUV encap-
sulating 4 or 30 μMAlexa488 and (ii) free Alexa488with totalmolecular
concentrations identical to those of the LUV stock solutions. The mixed
samples were vigorously vortexed before being transferred to the μ-
slide 8 wells for examination by FCS. FCS experiments were performed
with an excitation power of 10.9 μW. The data analysis was conducted
using Steps 1–4 of the data treatment protocol to evaluate the effect
of eB on the fractional amplitude of the free ﬂuorescent molecules,
yf = Af/(Af + Av).
Secondly, we evaluated the effect of the brightness ratio between
encapsulated and free ﬂuorescent molecules, k. For this purpose, we
prepared a series of samples to simulate a leakage experiment for two
different values of k. This series of samples was prepared from stock
solutions of (i) 1 mM POPC/POPG (3:1) LUV encapsulating 4 μM
Alexa488 and (ii) free Alexa488 with total molecular concentration
identical to that of the LUV stock solution. The mixed samples were
vigorously vortexed before being transferred to the μ-slide 8 wells for
AB
C
Fig. 2. Experimentally determined leakage value, L, vs simulated leakage value, Lsim, for
series of samples simulating a leakage process from 1 mM POPC/POPG (3:1) LUV encapsu-
lating 4 μMAlexa488 (A), 5 μMAlexa488-3kMW(B), or 2.5 μMAlexa488-10kMW(C). In all
panels, the data are the average of three separate experiments. The error bars show the
standard deviations. The error bars are not shown if they are smaller than the symbols.
The L-values at Lsim=0%and Lsim=100%are, by deﬁnition, set to 0% and100%, respectively.
The data conﬁrm that FCS can be used to accurately quantify leakage of ﬂuorescent
molecules of different sizes from LUVs.
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excitation powers of 10.9 and 43.2 μW, corresponding to k= 0.85 and
0.59, respectively. The data analysis was conducted using Steps 1–4 in
the data treatment protocol to evaluate the effect of k on Af.
Thirdly,we evaluated the interactions of Alexa488, Alexa488-3kMW,
Alexa488-10kMW, and Rh6Gwith POPC/POPG (3:1) LUVs. For this pur-
pose, we prepared samples with 40 nM of Alexa488, Alexa488-3kMW,
Alexa488-10kMW, or Rh6G in (i) buffer, (ii) solutions with 1 mM unla-
beled POPC/POPG LUV (3:1), or (iii) solutions with 1 mM unlabeled
POPC/POPG (3:1) LUV and 50 μM MPX. All samples were mixed in
Protein LoBind tubes and vigorously vortexed for a few seconds before
being transfered to the μ-slide 8 wells for examination by FCS. Experi-
ments were conducted with an excitation power of 10.9 μW. For the
data analysis, the diffusion time of the free ﬂuorescent molecules, τDf,
was determined by ﬁtting the single-component autocorrelation func-
tion (Eq. (1)) to the autocorrelation curves recorded from the samples
of free ﬂuorescent molecules in buffer. The LUV diffusion time, τDv,
was set to 4700 μs, a typical diffusion time for LUVs. The correction
parameter, z0, was set to 0.033 for Alexa488 and Rh6G, 0.028 for
Alexa488-3kMW, and 0.025 for Alexa488-10kMW, typical values of z0.
The rest of the data analysis was then conducted using Step 4 in the
data treatment protocol to determine the fractional amplitude of the
unbound ﬂuorescent molecules, yf = Af/(Af + Av), for each sample.
3.3.5. Interaction of MPX with POPC/POPG (3:1) LUVs
To investigate the capability of MPX to induce leakage from POPC/
POPG (3:1) LUVs, variable volumes of 100 μM MPX stock solutions
were transferred to Protein LoBind tubes containing POPC/POPG (3:1)
LUVs encapsulating 4 μM Alexa488, 5 μM Alexa488-3kMW, or 2.5 μM
Alexa488-10kMW. After addition of MPX, the ﬁnal LUV concentrations
of these samples were always 1 mM. Immediately after addition of
MPX, each sample was vigorously vortexed for a few seconds and sub-
sequently incubated for 1 h at room temperature. After this incubation
period, the samples were transferred to the μ-slide 8 wells for examina-
tion by FCS. Experiments were conducted with an excitation power of
10.9 μW. Leakage, L, was calculated using the data treatment protocol.
The diffusion times of Alexa488, Alexa488-3kMW, and Alexa488-
10kMW were used together with the Stokes–Einstein relationship to
determine the hydrodynamic radii of Alexa488, Alexa488-3kMW, and
Alexa488-10kMW to estimate the size of the transmembrane pores.
To evaluate the mechanism by which MPX induces leakage from
POPC/POPG (3:1) LUVs, variable volumes of 100 μM MPX stock solu-
tions were transferred to Protein LoBind tubes containing POPC/POPG
(3:1) LUVs labeled with TopFluor PC. After addition of MPX, the ﬁnal
LUV concentrations of these samples were always 1 mM. Immediately
after addition of MPX, each sample was vigorously vortexed for a few
seconds and subsequently incubated for 1 h at room temperature. After
this incubation period, the samples were transferred to the μ-slide 8
wells for examination by FCS. The excitation power of these FCS experi-
mentswas 2.6 μW.The recorded autocorrelation curveswereﬁtted using
the single-component autocorrelation function (Eq. (1)) to obtain infor-
mation about the effect of MPX on the apparent number of LUVs in the
excitation volume, N, and the LUV diffusion time, τD.
4. Results and discussion
4.1. Accuracy of the FCS method
Samples with varying degrees of encapsulated/free ﬂuorescentmol-
ecules and constant total concentration of ﬂuorescent molecules were
prepared in order to simulate a leakage process from 1 mM POPC/
POPG (3:1) LUV encapsulating 4 μM Alexa488, 5 μM Alexa488-3kMW,
or 2.5 μM Alexa488-10kMW. Fig. S2 in the Supporting material shows
some examples of autocorrelation curves recorded from these samples.
Fig. 2 shows the experimentally determined leakage level of these sam-
ples, L vs the simulated leakage level, Lsim. The good agreement betweenL and Lsim conﬁrms that FCS is applicable to accurately calculate leakage
from LUVs of ﬂuorescent molecules of different sizes.
4.2. Experimental pitfalls
In order to use FCS to obtain reliable estimates of leakage of ﬂuores-
cent molecules from LUVs, a number of experimental pitfalls should
be avoided. In the following sections, we highlight three of the most
prominent examples of such pitfalls.
4.2.1. Number of ﬂuorescent molecules encapsulated per LUV, eB
In a multicomponent autocorrelation function, written in a general-
ized form in Eq. (2), the amplitudepertaining to the ith species,Ai, scales
with the square of the brightness of that species, Bi2. Consequently,
species with very high brightness will dominate such multicomponent
autocorrelation functions. To illustrate the impact that this effect
Fig. 4. Experimentally determined amplitude of the free Alexa488, Af, vs simulated leakage
level, Lsim, for a series of samples simulating a leakage process from 1 mM POPC/POPG
(3:1) LUV encapsulating 4 μM Alexa488. FCS experiments were conducted for two
different brightness ratios between encapsulated and free ﬂuorescent molecules, k =
0.85 and 0.59, respectively. The data are the average of three separate experiments. The
error bars show the standard deviations. The error bars are not shown if they are smaller
than the symbols. The solid lines are calculated using Eq. S22 from the Supporting materi-
al. The data demonstrate that k should be kept close to 1 in order for Eq. 10 to be applicable
for calculating leakage.
2999K. Kristensen et al. / Biochimica et Biophysica Acta 1838 (2014) 2994–3002might have on the accuracy of the calculated leakage values, we pre-
pared two series of samples to simulate a leakage process from 1 mM
POPC/POPG (3:1) LUV encapsulating 4 or 30 μM Alexa488. These two
concentrations of encapsulated Alexa488 were from experiments
found to correspond to the apparent number of Alexa488 molecules
encapsulated per LUV,eB ¼ Bv=Be, being equal to 2.3 and9.5, respectively.
Fig. 3 shows the experimentally determined fractional amplitude of free
Alexa488, yf = Af/(Af + Av), as a function of the simulated leakage level,
Lsim, for the two series of samples. The solid lines in theﬁgure are plotted
using Eq. S20 from the Supporting material. The data in Fig. 3 clearly
demonstrate that the contribution of Af to the entire amplitude of the
autocorrelation curves decreaseswhen brightness of the LUVs increases.
This effect is especially pronounced for small values of leakage. Howev-
er, if Af only comprises a few percent of the entire amplitude of the
autocorrelation function, then it will in many cases be difﬁcult to obtain
a reliable estimate of Af, leading to poor resolution in the calculated leak-
age values. Along these lines, it can then be concluded that to use FCS to
accurately calculate leakage, the number of ﬂuorescent molecules
encapsulated per LUV, eB, should be kept as low as possible. However, a
lower limit to the number of ﬂuorescent molecules encapsulated per
LUV is dictated by the fact that a certain experimental photon count
rate signiﬁcantly above the background level is required. Accordingly,
optimal experimental designs to accurately calculate leakage by FCS
should balance the requirements for low numbers of ﬂuorescent
molecules per LUV and high photon count rates.4.2.2. Brightness ratio between encapsulated and free ﬂuorescent
molecules, k
Tomeet the requirement for a low number of ﬂuorescent molecules
per LUV, a high photon count rate per ﬂuorescent molecule is required.
One way to increase the photon count rate per ﬂuorescent molecule
is to increase the intensity of the excitation source. However, we
found that increasing the excitation intensity might signiﬁcantly affect
the ratio between the brightness of encapsulated and free ﬂuorescent
molecules, k. One possible hypothesis on the origin of this effect is that
encapsulated ﬂuorescent molecules are subject to a different local envi-
ronment than free ﬂuorescent molecules, causing the photophysical
properties of encapsulated and free ﬂuorescent molecules to be differ-
ent. Another possible hypothesis is that the encapsulated ﬂuorescent
molecules are photobleached at a higher rate than the free ﬂuorescent
molecules; however, speaking against this latter hypothesis is the factFig. 3. Experimentally determined fractional amplitude of free Alexa488, yf = Af/(Af + Av),
vs simulated leakage level, Lsim, for two series of samples simulating a leakage process
from 1 mM POPC/POPG (3:1) LUV encapsulating 4 or 30 μM Alexa488, corresponding to
the apparent number of Alexa488 encapsulated per LUV, eB, being equal to 2.3 and 9.5, re-
spectively. The data are the average of three separate experiments. The error bars show
the standard deviations. The error bars are not shown if they are smaller than the symbols.
The solid lines are calculated using Eq. S20 from the Supportingmaterial. The results dem-
onstrate that the concentration of ﬂuorescentmolecules inside the LUVs should be kept as
low as possible for FCS to be used to accurately calculate leakage.that the shape of the experimental autocorrelation curves does not
signiﬁcantly depend on the excitation intensity.
To evaluate the effect of k on the capability of FCS to accurately
calculate leakage, we prepared a series of samples to simulate a leakage
process from1mMPOPC/POPG (3:1) LUVencapsulating 4 μMAlexa488.
Two different excitation intensities, resulting in k = 0.85 and 0.59,
respectively, were employed in the FCS experiments. Fig. 4 shows the
experimentally determined amplitude of free Alexa488, Af, as a function
of the simulated leakage level, Lsim, as obtained using the two different
excitation intensities. The solid lines in the ﬁgure are plotted using
Eq. S22 from the Supporting material. For both excitation intensities,
we observe that Af is a monotonic function of Lsim, albeit for k = 0.59,
we observe that Af levels off at high values of Lsim. Thus, the data in
Fig. 4 illustrate a problem arising when k is decreasing, namely, that
the sensitivity of Af to changes in leakage diminishes at high values of
leakage. In addition, for even smaller values of k than those studied in
Fig. 4, Eq. S22 from the Supporting material predicts a non-monotonic
dependence of Af to L, rendering Eq. (10) inapplicable to estimate
leakage. We can thus conclude that the excitation intensity should be
tuned to obtain k-values close to 1 in order for Eq. (10) to be applicable
to accurately calculate leakage.4.2.3. Interaction of ﬂuorescent molecules with POPC/POPG (3:1) LUVs
Another important part of the experimental design is the choice of
ﬂuorescentmolecules to be encapsulated inside the LUVs. In the present
article, we used the hydrophilic anionic dye Alexa488, unconjugated or
conjugated to dextran molecules. Another popular choice of dye for
leakage studies by FCS is the cationic dye Rh6G. To investigate the
suitability of each of these dyes for leakage experiments by FCS, we
prepared series of samples in which 40 nM Alexa488, Alexa488-3kMW,
Alexa488-10kMW, or Rh6G was mixed with (i) buffer, (ii) 1 mM unla-
beled POPC/POPG (3:1) LUV, or (iii) 1 mM POPC/POPG (3:1) LUV and
50 μMMPX. Fig. 5 shows the fractional amplitude of theunboundﬂuores-
cent molecules, yf = Af/(Af + Av), for the samples. For Alexa488,
Alexa488-3kMW, and Alexa488-10kMW, yf was always found to be
close to 100%, indicating that none of these ﬂuorescent molecules bind
to the POPC/POPG (3:1) LUVs. In contrast, mixing Rh6G with 1 mM
POPC/POPG (3:1) LUV yielded yf = 11%, indicating that a large fraction
of the cationic Rh6G molecules bind to the surfaces of the anionic LUVs
and thereby that Rh6Gmight be a poor choice of dye for leakage studies,
at least under the experimental conditions used in this article. The risk of
using Rh6G is further emphasized by the observation that when MPX is
Fig. 5. Fractional amplitude of the unbound ﬂuorescent molecules, yf = Af/(Af + Av), for
samples with 40 nM Alexa488, Alexa488-3kMW, Alexa488-10kMW, or Rh6G in (i) buffer,
(ii) 1 mM unlabeled POPC/POPG (3:1) LUV, or (iii) 1 mM POPC/POPG (3:1) LUV and
50 μMMPX. The data are the average of three separate experiments. Error bars show the
standard deviations. The data show that Alexa488, Alexa488-3kMW, and Alexa488-
10kMW do not interact with the LUVs. In contrast, Rh6G clearly interacts with the LUVs.
Upon addition of MPX, a signiﬁcant fraction of the Rh6G molecules dissociates from the
LUVs and/or the coverslips. This peptide-induced unbinding might easily be confused
with peptide-induced leakage from LUVs.
A
3000 K. Kristensen et al. / Biochimica et Biophysica Acta 1838 (2014) 2994–3002present together with the LUVs, then yf of Rh6G increase to 47%. Thus,
the presence MPX entail an increasing contribution of unbound Rh6G
to the autocorrelation function, probably because the polycationic MPX
causes unbinding of Rh6G from the LUVs and/or the coverslips due to
an entropy-driven counterion release effect. Such peptide-induced
unbinding of Rh6G from the LUVs and coverslipsmight easily bemistak-
en for peptide-induced leakage from the LUVs. Thus, great caution
should be taken when using Rh6G as the ﬂuorescent marker in leakage
experiments.
4.3. Interaction of MPX with POPC/POPG (3:1) LUVs
WeusedMPX to demonstrate the potential of our FCS-based protocol
to study leakage. Fig. 6 showsMPX-induced leakage, L, vs the peptide-to-
lipid ratio, [P]/[L] ratio, for samples in which variable concentrations of
MPXhadbeen incubated for 1 hwith 1mMPOPC/POPG (3:1) LUVencap-
sulating 4 μM Alexa488, 5 μM Alexa488-3kMW, or 2.5 μM Alexa488-
10kMW. From the ﬁgure, it is clear that MPX-induced leakage from
POPC/POPG (3:1) LUVs is dependent on the size of the encapsulatedFig. 6.MPX-induced leakage, L, from1mMPOPC/POPG (3:1) LUVvs [P]/[L] ratio for samples
inwhichMPXhad been incubated for 1 hwith the LUVs. The LUVswere encapsulating 4 μM
Alexa488, 5 μMAlexa488-3kMW, or 2.5 μMAlexa488-10kMW. The data are the average of
three separate experiments. The error bars show the standard deviations. The leakage
values at the lowest and highest peptide-to-lipid ratios of a given experimental series
correspond to 0% and 100% leakage, respectively, and, therefore they are, by deﬁnition,
always set to 0% and 100%, respectively. Sigmoidal trendlines are added to guide the eye.
Smaller ﬂuorescent molecules were more effectively released than larger ﬂuorescent
molecules.ﬂuorescent molecules; for example, Alexa488 was completely leaked
out at [P]/[L] = 0.025, whereas only ~58% and ~23% of Alexa488-
3kMW and Alexa488-10kMW, respectively, were leaked out at the
same [P]/[L] ratio. However, at higher [P]/[L] ratios, Alexa488-3kMW
and Alexa488-10kMW were also completely leaked out. Such size-
dependent leakage has also previously been reported for MPX [24].
Fig. S3 in the Supporting material shows leakage at selected [P]/[L]
ratios recorded after 10 min, 20 min, 1 h, and ~18 h incubation of MPX
with POPC/POPG (3:1) LUVs. These data demonstrate that MPX-
induced leakage of all three ﬂuorescent molecules is a partial transient
process, in which a rapid burst of leakage within the ﬁrst few minutes
is followed by a dramatic slowing down or complete cessation of leak-
age. Such biphasic leakage kinetics has previously been reported for
MPX [21–25] as well as for many other antimicrobial peptides [31].
Due to this biphasic leakage kinetics, the leakage values recorded from
samples incubated for 1 h are, by and large, representative of the leakage
occurringwithin the ﬁrst fewminutes after addition ofMPX to the LUVs.
To investigate whether MPX-induced leakage is due to formation of
transmembrane pores or due to membrane solubilization, we incubated
MPX together with 1mMTopFluor PC-labeled POPC/POPG (3:1) LUV for
1 h. Fig. 7 shows the apparent mean number of LUVs in the excitation
volume, N, and the LUV diffusion time, τD, vs the [P]/[L] ratio for these
samples. From the ﬁgure, it is clear that both N and τD are largely inde-
pendent of the [P]/[L] ratio. This observation strongly suggests that the
LUVs remain intact during the leakage process; therefore, when held
together with the data in Fig. S3, the data in Fig. 7 indicates that MPX-
induced release of encapsulated molecules is due to the formation of
transient transmembranepores andnot due tomembrane solubilization.B
Fig. 7. Interaction of MPX with 1 mM TopFluor PC-labeled POPC/POPG (3:1) LUV. (A) The
apparent mean number of LUVs in the excitation volume, N, vs [P]/[L] ratio. (B) The LUV
diffusion time, τD, vs the [P]/[L] ratio. Data was recorded after 1 h incubation of MPX with
the LUVs. The data are the average of three separate experiments. The error bars show the
standard deviations. Error bars are not shown if they are smaller than the symbols. The
fact that N and τD are largely independent on the [P]/[L] ratio indicate that leakage is due
to the formation of transmembrane pores and not due to membrane solubilization.
3001K. Kristensen et al. / Biochimica et Biophysica Acta 1838 (2014) 2994–3002This is in accordance with previously published data that shows that
MPX only solubilizes POPC/POPG (3:1) LUVs at higher [P]/[L] ratios
than what we consider in this article [32].
From the release proﬁles of Alexa488 and Alexa488-labeled dextrans
in Fig. 6, we can get an estimate of the pore size. Thus, at low [P]/[L]
ratios, Alexa488, with a hydrodynamic radius of ~0.6 nm, was more
effectively released than were Alexa488-3kMW, with a hydrodynamic
radius of ~1.3 nm, and Alexa488-10kMW, with a hydrodynamic radius
of ~2.7 nm. This observation suggests that the typical pore radius at
low [P]/[L] ratios is between ~0.6 nm and ~2.7 nm, in rough agreement
with pore sizes previously suggested for MPX [24] as well as other anti-
microbial peptides [5,6,33]. At higher [P]/[L] ratios, the Alexa488-labeled
dextrans were completely released, suggesting that the pore radius at
higher [P]/[L] ratio increases to above ~2.7 nm. However, the pore radii
estimated from the hydrodynamic radii of the dextranmolecules should
be regarded with caution. Thus, dextran molecules are not perfect
spheres with well-deﬁned radii. Rather, dextran molecules are modeled
as prolate ellipsoids with a short axis and a long axis, complicating
attempts of relating their hydrodynamic radius to pore sizes [34]. In
addition, it has been suggested that dextran molecules might pass
through peptide-induced pores by reptation, further complicating the
use of dextran molecules for sizing the pores [5]. Therefore, other types
of ﬂuorescently-labeled macromolecules might be more appropriate
for accurately estimating the size of transmembrane pores. Nevertheless,
in this article, we chose to use dextrans as that is also the common choice
in most other articles in the literature. Under all circumstances, the data
in Figs. 6 and 7 demonstrate that FCS can be used to obtain a high level of
insight into themechanisms underlying leakage induced by antimicrobi-
al peptides aswell as other leakage-inducing agents. The advantages and
limitations of FCS as a method for studying leakage from LUVs are
discussed in more detail in the following section.
4.4. Advantages and limitations of FCS as a method for studying leakage
from LUVs
The central limitation of FCS as compared to the conventional
quenching-based leakage assays is that FCS does not provide detailed
information about the kinetics of the leakage process. In this article,
we have used an experimental acquisition time of 5 min. This acquisi-
tion time could be shortened to approximately 1 min at the cost of
slightly higher uncertainties in the calculated leakage values, but any
leakage kinetics occurring on a time scale much faster than 1 min is
beyond reachby FCS. However, in spite of this limitation, FCS still presents
a number of interesting experimental advantages when compared to the
conventional quenching-based leakage assays.
First, calculation of leakage by FCS is independent on the leakage
mode of the ﬂuorescent molecules. More speciﬁcally, calculation of
leakage by FCS is independent onwhether leakage proceeds by a graded
process, in which all LUVs release part of their contents, or an all-or-
none process, in which part of the LUVs release all of their contents
and part of the LUVs release no contents. This is a great advantage of
FCS as compared to the conventional quenching-based leakage assays
in which the self-quenching factor of encapsulated ﬂuorescent mole-
cules is highly dependent on the nature of the leakage process [3,4].
Second, FCS requires only very low concentrations of ﬂuorescent
molecules inside the LUVs. Consequently, in a typical FCS leakage exper-
iment, only a few ﬂuorescent molecules are encapsulated in each LUV.
Accordingly, when studying leakage by FCS, investigators are free to sys-
tematically vary the osmolarity and ionic strengths of the buffers inside
and outside the LUVs. In contrast, the experimental designs in the con-
ventional quenching-based leakage assays are restricted by the fact that
ﬂuorophore concentrations inside the LUVs have to be in themillimolar
range to obtain quenching [3,4].
Third, as discussed in Section 4.3, FCS can be used to obtain rapid
estimates of pore sizes in LUVs. Such estimates of pores sizes can, in prin-
ciple, also be obtained by the conventional quenching-based leakageassays. However, as mentioned before, the quenching-based assays
require that the concentration of ﬂuorophores inside the LUVs be
in the millimolar range; thus, if the ﬂuorophores are conjugated to
size marker molecule, such as dextran molecules, then the mass con-
centration of the size marker molecules inside the LUVs will be ex-
tremely high. In the FCS experiments, these crowded environments
inside the LUVs will be avoided, minimizing risks that the kinetics
of the leakage process will be affected by intermolecular interactions
between the encapsulated size marker molecules. It should be men-
tioned that estimates of pore sizes in LUVs have also been obtained
by chromatographic separation of LUVs from released ﬂuorescent
size marker molecules [5,6]. Although these chromatography-
based methods require lower size marker concentrations than the
conventional quenching-based leakage assays, they still require
signiﬁcantly higher concentrations than FCS.
Fourth, FCS revealswhether leakage is due to the formation of trans-
membrane pores or due to detergent-like solubilization of the lipid
membrane [7,8]. In this article, we have evaluated themembrane integ-
rity in a separate experiment on TopFluor PC-labeled LUVs. However, it
should be mentioned that it would also be possible to measure leakage
and membrane integrity in one single and fast two-color FCS experi-
ment by considering leakage of a ﬂuorescent marker that is spectrally
separated from a membrane-anchored dye.5. Conclusions
In this work, we considered FCS as a technique to study leakage of
ﬂuorescent molecules from large unilamellar lipid vesicles (LUVs). For
this endeavor, we derived the necessary theoretical framework, and we
highlighted the experimental pitfalls that might lead to inaccurate and/
or false conclusions. To avoid these pitfalls, we showed that (i) the num-
ber of ﬂuorescent molecules per LUV should be low, (ii) the brightness
ratio between encapsulated and free molecules should be close to 1,
and (iii) control experiments should ensure that the ﬂuorescent mole-
cules do not interact with the LUVs. FCS was then used to investigate
leakage induced by the antimicrobial peptide mastoparan X (MPX). We
showed that MPX induce size-dependent partial transient leakage from
POPC/POPG (3:1) LUVs, and that leakage is due to the formation of tran-
sient transmembrane pores. In the ﬁnal discussion, we concluded that
FCS displays one central limitation when compared to the conventional
quenching-based leakage assays, namely that the time resolution of the
FCS experiments is poorer than the time resolution of the quenching-
based assays. However, in the ﬁnal discussion, we also concluded that
FCS displays a number of advantages when compared to other existing
methods to study leakage: (i) calculation of leakage by FCS is indepen-
dent on whether the leakage process is an all-or-none process or a
graded process, whereas calculation of leakage by the conventional
quenching-based methods requires that the leakage mode is taken
explicitly into account; (ii) FCS requires a much lower concentration of
encapsulated ﬂuorescent molecules per LUV than does other existing
methods, allowing investigators to more freely vary the experimental
conditions; (iii) FCS provides a fast method for sizing of transmembrane
pores; and (iv) FCS reveals whether leakage is due to the formation of
transmembrane pores or membrane solubilization.Acknowledgements
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